Atomi Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11M Sell
4,209
-1,005
-19% -$482K 0.06% 256
2026
Q1
$2.56M Sell
5,214
-5,851
-53% -$3.18M 0.08% 200
2025
Q4
$6.41M Buy
11,065
+6,577
+147% +$3.72M 0.19% 93
2025
Q3
$2.18M Buy
4,488
+530
+13% +$247K 0.07% 193
2025
Q2
$1.6M Sell
3,958
-34
-0.9% -$14.2K 0.06% 225
2025
Q1
$1.99M Buy
3,992
+1,373
+52% +$744K 0.09% 171
2024
Q4
$1.36M Sell
2,619
-210
-7% -$115K 0.07% 208
2024
Q3
$1.75M Buy
2,829
+1,269
+81% +$751K 0.11% 152
2024
Q2
$863K Buy
1,560
+156
+11% +$89.4K 0.06% 245
2024
Q1
$816K Buy
1,404
+317
+29% +$178K 0.08% 221
2023
Q4
$577K Buy
1,087
+365
+51% +$177K 0.08% 237
2023
Q3
$365K Buy
+722
New +$385K 0.12% 203

Other funds holding TMO

Atomi Financial Group's TMO Position: Q2 2026 in Review

Atomi Financial Group reduced its Thermo Fisher Scientific (TMO) stake by 19% in Q2 2026, selling an estimated $482K and leaving 4,209 shares worth $2.11M. The position accounts for 0.06% of the portfolio, ranked #256.

Atomi Financial Group first reported a position in TMO in Q3 2023 and has held it in 12 quarters since. The position peaked at $6.41M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Atomi Financial Group held 4,209 shares of Thermo Fisher Scientific worth $2.11M as of Q2 2026.
  • Atomi Financial Group sold 1,005 Thermo Fisher Scientific shares in Q2 2026, an estimated $482K.
  • Thermo Fisher Scientific made up 0.06% of Atomi Financial Group's portfolio in Q2 2026, its #256 holding.
  • Atomi Financial Group first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 12 quarters since.
  • Atomi Financial Group's Thermo Fisher Scientific position peaked at $6.41M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.